Alhamadani I, Alzyadi M, Majeed M. Prognostic Significance of the CXCL11/CXCL9/CD163 Immune Signature in Triple-Negative Breast Cancer: A Bioinformatics and Survival Analysis: CXCL11/CXCL9 prognostic value. Arch Breast Cancer [Internet]. 2026 Apr. 22 [cited 2026 May 30];13(2):154-65. Available from: https://www.archbreastcancer.com/index.php/abc/article/view/1224